GeoVax Labs Inc.

01/22/2025 | Press release | Distributed by Public on 01/22/2025 15:02

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company re-convened a special meeting of stockholders on January 22, 2025 (originally convened on September 17, 2024). The Company received proxies totaling 1,675,334 of its 5,013,700 issued and outstanding shares of common stock as of the record date of July 22, 2024, representing 33.4% of the outstanding shares of common stock entitled to vote. The stockholders voted on the following proposals and the results of the voting are presented below.
Approval of the May 2024 Warrant Exercise Proposal
Our stockholders approved a proposal to approve, pursuant to Nasdaq listing rules, the issuance of up to 1,605,688 shares of our common stock upon exercise of a common stock purchase warrant issued to an institutional investor in connect with the private placement offering which occurred on May 16, 2024. There were no broker non-votes on this item.
For Against Abstain
1,294,141 287,649 93,544
Approval of the July 2024 Warrant Exercise Proposal
Our stockholders approved a proposal to approve, pursuant to Nasdaq listing rules, the issuance of up to 2,170,000 shares of our common stock upon exercise of a common stock purchase warrant issued to an institutional investor in connect with the private placement offering which occurred on July 11, 2024. There were no broker non-votes on this item.
For Against Abstain
1,306,150 275,705 93,479